Literature DB >> 11279678

Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.

D L Phelps1, J L Watts.   

Abstract

BACKGROUND: Retinopathy of prematurity (ROP) causes vision loss in many premature infants each year, despite the advances being made in treatment. In the search for ways to prevent the disease altogether, the exposure of the retina to bright ambient light following premature birth has been a natural hypothesis, since the premature infant normally would be in the dark in-utero environment. Several controlled studies have now addressed this theory.
OBJECTIVES: To answer the question: "Among very low birth weight infants, what is the effect of reducing early environmental light exposure on the incidence of any "Acute ROP", or "Poor ROP Outcomes"? SEARCH STRATEGY: Searches were made of the Cochrane Neonatal Group Register of Controlled Trials, Medline, EMBASE, the Cochrane Library, previous reviews including cross references, abstracts, conference and symposia proceedings, and expert informants. The search terms used were [retrolental fibroplasia or retinopathy of prematurity] and [light or light/ae or lighting or lighting/ae or light/tu or lighting/st]. This search was updated as of November 2000. SELECTION CRITERIA: Randomized or quasi-randomized controlled trials that reduced light exposure to premature infants within the first 7 days following birth were considered for this review. DATA COLLECTION AND ANALYSIS: Data on clinical outcomes including any Acute ROP and Poor ROP Outcome were excerpted by both reviewers independently and consensus reached. Data analysis was conducted according to the standards of the Neonatal Cochrane Review Group. MAIN
RESULTS: Data from four recent randomized trials, and one much older quasi-randomized trial failed to show any reduction in Acute ROP, or Poor ROP Outcome with the reduction of ambient light to premature infants' retinas. The number of infants studied to date allows 95% confidence that IF there were a true difference being missed, it would be smaller than 7 percentage points on a background of 54% of all infants under 2 kg developing ROP. REVIEWER'S
CONCLUSIONS: Decreasing retinal ambient light exposure in premature infants is very unlikely to reduce the incidence of ROP.

Entities:  

Mesh:

Year:  2001        PMID: 11279678     DOI: 10.1002/14651858.CD000122

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  9 in total

1.  Effect of light reduction on the incidence of retinopathy of prematurity.

Authors:  R R T Braz; M E L Moreira; M de Carvalho; J M A Lopes; M A Rodrigues; J A O Cabral; M M Motta
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03-17       Impact factor: 5.747

Review 2.  Iatrogenic environmental hazards in the neonatal intensive care unit.

Authors:  Thomas T Lai; Cynthia F Bearer
Journal:  Clin Perinatol       Date:  2008-03       Impact factor: 3.430

Review 3.  Does reducing light exposure decrease the incidence of retinopathy of prematurity in premature infants?

Authors:  Christine Johannes; Kimberly Dow
Journal:  Paediatr Child Health       Date:  2013-06       Impact factor: 2.253

4.  Timing for the Introduction of Cycled Light for Extremely Preterm Infants: A Randomized Controlled Trial.

Authors:  Debra H Brandon; Susan G Silva; Jinhee Park; William Malcolm; Heba Kamhawy; Diane Holditch-Davis
Journal:  Res Nurs Health       Date:  2017-04-21       Impact factor: 2.228

Review 5.  Cycled light in the intensive care unit for preterm and low birth weight infants.

Authors:  Iris Morag; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2016-08-10

Review 6.  The neural retina in retinopathy of prematurity.

Authors:  Ronald M Hansen; Anne Moskowitz; James D Akula; Anne B Fulton
Journal:  Prog Retin Eye Res       Date:  2016-09-23       Impact factor: 21.198

Review 7.  Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.

Authors:  Eliane C Jorge; Edson N Jorge; Regina P El Dib
Journal:  Cochrane Database Syst Rev       Date:  2013-08-06

Review 8.  [Risk factors and prevention of retinopathy of prematurity].

Authors:  L Pelken; R F Maier
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

9.  Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study.

Authors:  Medardo Avila-Vazquez; Roque Maffrand; Mirta Sosa; Maria Franco; Beatriz Vaca De Alvarez; Maria Luisa Cafferata; Eduardo Bergel
Journal:  BMC Pediatr       Date:  2004-08-07       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.